Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001345099-25-000049
Filing Date
2025-06-12
Accepted
2025-06-12 07:57:00
Documents
5
Period of Report
2025-06-12

Document Format Files

Seq Description Document Type Size
1 6-K a2025-06x12mesoblastmainta.htm 6-K 20386
2 EX-99.1 exhibit991.htm EX-99.1 10191
3 exhibit991001.jpg GRAPHIC 293994
4 exhibit991002.jpg GRAPHIC 294107
5 exhibit991003.jpg GRAPHIC 31710
  Complete submission text file 0001345099-25-000049.txt   885553
Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000
Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036
MESOBLAST LTD (Filer) CIK: 0001345099 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-37626 | Film No.: 251041672
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)